<DOC>
	<DOCNO>NCT00960453</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics pharmacodynamics sitagliptin healthy volunteer .</brief_summary>
	<brief_title>Clinical Trial Investigate Pharmacokinetics/Pharmacodynamics Sitagliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Healthy male subject age 20 50 year A body mass index ( BMI ) range 1728 kg/m2 Fasting plasma glucose level range 70110 mg/dL Sufficient ability understand nature study hazard participate Provide write informed consent fully inform study procedure Presence history severe adverse reaction drug ( e.g. , sitagliptin ) history severe allergic disease Clinically relevant abnormal medical history could interfere objective study A subject follow screen laboratory test result ; creatinine clearance ( calculate CockcroftGault equation ) &lt; 80 mL/min History gastrointestinal disease surgery ( except simple appendectomy repair hernia ) , influence absorption study drug A subject whose SBP 150 mmHg 100 mmHg DBP 95 mmHg 65 mmHg Presence history drug abuse Participation clinical trial within 2 month Use prescription medicine , herbal medicine within 2 week overthecounter medication within 1 week first dose Blood donation 2 month apheresis 1 month study Presence history alcohol abuse Users nicotinecontaining substance within previous three month Use grapefruit juice , alcohol smoking restriction period Subject judge eligible study participation investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>